It has been shown that human breast cancer can evolve from a TGF- β sensitive to a TGF-β resistant stage, and one of the mechanisms is activation of COX-2/EP4 pathway, making the cells unresponsive to TGF-β mediated phosphorylation of Smad352. Here, PTGS2 is linked to breast carcinoma.